MIF and sarcopenia: Despite some studies noting elevated MIF levels in certain inflammatory myopathies, we found reduced MIF in PCDS participants, and considering that PCDS could signify early‐stage accelerated aging phenotypes before sarcopenia and dementia, higher MIF levels could potentially suggest progressive muscle loss and inflammation at the later stage.